Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation.
about
Effects of a Particular Heptapeptide on the IFN-α-Sensitive CML Cells.Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib.Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation.
P2860
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@en
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@nl
type
label
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@en
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@nl
prefLabel
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@en
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@nl
P2093
P50
P1476
Interferon-alpha may restore s ...... leukaemia with F317L mutation.
@en
P2093
Alessandra Gnani
Eleonora Zanetti
Fabio Forghieri
Francesco Volzone
Giovanni Riva
Giuseppe Torelli
Mario Luppi
Monica Maccaferri
Monica Morselli
Patrizia Barozzi
P304
P356
10.1111/J.1365-2141.2009.07747.X
P407
P50
P577
2009-05-26T00:00:00Z